According to a new report by UnivDatos, the Embolotherapy Market is expected to reach USD million in 2033 by growing at a CAGR of 8.1%. Key Highlights of the Report: Ø The growing cases of liver cancer, uterine fibroids, and arteriovenous malformations (AVMs) are a major growth factor for the rising demand for the embolotherapy market. Ø Based on the product type...

According to UnivDatos analysis, rising prevalence of liver cancer, uterine fibroids, and vascular disorders, technological advancements in embolic agents, and growing FDA approvals are the major factors driving the growth of the embolotherapy market. As per their “Embolotherapy Market” report, the global market was valued at USD 4,084.29 million in 2024, growing at a CAGR of about...